Open AccessPrevalence of and risk factors for vitamin B 12 deficiency in patients with Crohn's disease
Author(s) -
Headstrom Peggy D.,
Rulyak Stephen J.,
Lee Scott D.
Publication year - 2008
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1002/ibd.20282
Subject(s) - medicine , odds ratio , gastroenterology , crohn's disease , ulcerative colitis , population , confidence interval , risk factor , disease , medical record , environmental health
Background: Crohn's disease (CD) can commonly involve the terminal ileum, which is the site of B 12 absorption. The aim of this study was to define the prevalence of vitamin B 12 abnormalities in a population with CD and to identify risk factors associated with B 12 abnormalities in CD. Methods: The medical records of 201 patients with CD evaluated at a tertiary care center were retrospectively reviewed to determine the prevalence of B 12 deficiency and to evaluate factors associated with B 12 deficiency. The prevalence of B 12 deficiency in a control population of 40 patients with ulcerative colitis was also assessed. Results: The prevalence of an abnormal serum B 12 concentration in patients with CD was 18.4% (95% confidence interval [CI] 13.1–23.8%) compared with 5% (95% CI, 0–11.8%) ( P = 0.035) in ulcerative colitis controls. Risk factors for B 12 deficiency in patients with CD included prior ileal (odds ratio [OR], 7.22; 95% CI, 1.97–26.51) or ileocolonic (OR, 5.81; 95% CI, 2.09–16.12) resection and the need for ongoing medical therapy (OR, 2.59; 95% CI, 1.03–6.47). Neither disease location nor duration was independently associated with the risk of B 12 deficiency. Conclusions: Vitamin B 12 abnormalities are common in patients with CD and patients with a prior ileal or ileocolonic resection are at particular risk. Routine screening for B 12 deficiency in patients with CD is warranted. (Inflamm Bowel Dis 2007)